Point of Care Deployments
A new generation of sequencing technology, at point of care
Alamya Health has the expertise you need to upgrade your laboratory’s product offerings to include Oxford Nanopore Technologies’ long-read sequencing at clinical grade.
Deploying and implementing new technology can be challenging and complex. It also requires a significant workforce investment that may not be readily available for your laboratory team. Alamya Health offers effective process management to support research and/or CLIA/CAP accredited laboratories in implementing the latest Oxford Nanopore sequencing technologies.
We can provide the expertise to get you from sample to report. Our team of project, technical, and medical professionals will facilitate deployment from concept through to completion. For CLIA/CAP accredited laboratories, this can include clinical validation of long-read sequencing as a laboratory diagnostic test.
When you choose to partner with Alamya Health, we will guide you through:
ONE
Planning & Installation
Our partnership begins with a consultation involving your team of experts and ours to scope your site requirements and timeline needs.
We will work with you to prepare your site for installation of our recommended Oxford Nanopore PromethION and Alamya Health’s supporting software services.
TWO
Training with Oxford Nanopore
Alamya Health will liaise between the Oxford Nanopore training team and your site to train team members who are new to the technology and familiarize them with the PromethION workflow.
THREE
Workflow Validation
As your team becomes familiar with the new sequencer, Alamya Health and your technologists will embark on improving proficiency and efficiency. This will include sequencing standardized sample sets. Our bioinformatics, software, and medical team will provide comprehensive input to ensure your team is meeting benchmarked performance parameters. This will ensure the writing of quality reports once your site is ready.
FOUR
Clinical Validation
Alamya Health will work with the site to clinically validate Oxford Nanopore long-read sequencing in a phased approach, based on variant classification type.
We offer continued operational, hardware and software support throughout the lifetime of your hardware installation.
If you are interested in more information regarding a point of care deployment, please contact us at orders@alamyahealth.com